Jun 16, 2022 / 01:30PM GMT
David Turkaly - JMP Securities LLC - Analyst
This is the one we've been waiting for.
Tony Koblish - TELA Bio, Inc. - Co-Founder, President & CEO
All right, David. Appreciate it.
Questions and Answers:
David Turkaly - JMP Securities LLC - AnalystYes, this is TELA Bio, one of our top picks. We have Tony and Roberto from the Company here with me. Obviously the last couple years have been challenging for a number of reasons, but I feel like you guys have managed to grow really well through it. So, I guess talk a little bit about what's gone on hernia with COVID and now beyond -- hopefully, beyond sort of what you're seeing from a volume or rebound in hernia procedures?
Tony Koblish - TELA Bio, Inc. - Co-Founder, President & CEO
Yes. So, we likely were the last MedTech company, one of the last MedTech companies to go public before COVID hit. And then we were implementing our first big GPO contract with HealthTrust in March of 2020 just as COVID hit. And what we